Transcutaneous Vagus Nerve Stimulation (taVNS) Dosage Study 1
NCT06381102
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Healthy
Interventions
DEVICE:
transcutaneous auricular vagus nerve stimulation 30/30
DEVICE:
transcutaneous auricular vagus nerve stimulation 10/10
Sponsor
University of Miami